
AST results: where review matters
What a CMAC study reveals about AST interpretation standards, categorization errors and expert review of microbiology results.
Open resourceResearch, reviews, and analytical reports on clinical microbiology, antimicrobial resistance, and antimicrobial therapy.

What a CMAC study reveals about AST interpretation standards, categorization errors and expert review of microbiology results.
Open resource
What a systematic review of 382 studies says about resistant-pathogen risk factors, prediction models, and the need for local validation.
Open resource
How microbiological diagnosis, result interpretation, resistance surveillance, antimicrobial use and evaluation of clinical and economic outcomes fit together.
Open resourceEUCAST has published an updated assessment of whole-genome sequencing for predicting bacterial antimicrobial susceptibility. We examine how far genotype can replace phenotype today and why linking both types of data is increasingly important.
Open resource
From random forests and convolutional neural networks to genomic language models: how machine learning is used to predict bacterial antimicrobial resistance, and why data remain the central challenge.
Open resource
Key results of the 2025 analytical report by the Methodological Verification Center on antimicrobial resistance: pathogen structure among hospitalized patients, resistance levels, carbapenemases, and practical conclusions regarding antimicrobial agents.
Open resource
A review from CMAC (2025) compares WHO GLASS, CLSI M39, ESCMID, AMRcloud guidance and Russian MR 3.1.0346-24–highlighting key contradictions that matter for local antibiograms, data quality, and stewardship decisions.
Open resource
How susceptibility testing accuracy, prescribing errors, and AMR diagnostics translate into measurable economic losses–and why even a 10% error rate can cost millions of rubles.
Open resource